Friday, April 29, 2011 4:07:28 PM
Exhibit 99.1 PRESS RELEASE
Vivakor Announces Termination of Memorandum of Understanding to Merge with Resolution Biomedical.
Irvine, CA, April 29, 2011 (GLOBE NEWSWIRE) -- Vivakor, Inc. (OTCBB:VIVK) announced today that the parties have mutually agreed to terminate their memorandum of understanding to merge Vivikor with Resolution Biomedical, Inc. due primarily to the inability to secure acceptable financing terms. Vivakor continues to seek interested merger and acquisition candidates.
About Vivakor, Inc.
Vivakor™ is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds that extend or improve life. More information can be found about Vivakor at www.vivakor.com.
FORWARD-LOOKING STATEMENTS
This press release may contain forward-looking statements, including, but not limited to, statements regarding Vivakor's products and their related market potential. Forward-looking statements may be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to, risks and uncertainties discussed in Vivakor's filings with the Securities and Exchange Commission, which factors are incorporated herein by reference. Readers are cautioned not to place undue reliance on any of these forward-looking statements. Vivakor undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect actual outcomes.
Contact:
Vivakor Investor Relations
info@vivakor.com
Recent VIVK News
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 09:28:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 09:25:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/30/2024 12:41:40 AM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 05/23/2024 01:25:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/20/2024 09:29:33 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 05/16/2024 08:30:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 09:06:58 PM
- Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm • PR Newswire (US) • 03/15/2024 04:53:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:00:24 PM
- Socially Responsible Energy Operator Announces Planned Acquisition, Sending Shares Higher • AllPennyStocks.com • 03/04/2024 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:10:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2024 10:17:46 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/09/2024 10:11:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:44:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/11/2024 10:00:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/21/2023 09:30:19 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 12/12/2023 10:26:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/12/2023 09:45:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 11/24/2023 10:10:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/24/2023 09:30:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:41:29 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/17/2023 04:20:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/15/2023 01:49:21 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/01/2023 01:25:35 PM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM